cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Celldex Therapeutics Inc
4 own
23 watching
Current Price
$46.09
$1.11
(2.47%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
2,170.66M
52-Week High
52-Week High
48.4
52-Week Low
52-Week Low
19.85
Average Volume
Average Volume
0.35M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization2,170.66M
icon52-Week High48.4
icon52-Week Low19.85
iconAverage Volume0.35M
iconDividend Yield--
iconP/E Ratio--
What does the Celldex Therapeutics Inc do?
Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. Its drug candidates include glembatumumab vedotin, an antibody-drug that is in Phase IIb study for the treatment of triple negative breast cancer and a Phase II study for the treatment of metastatic melanoma; and Varlilumab, an immune modulating antibody that is in a Phase 1 study designed to enhance a patient's immune response against cancer. It also develops earlier stage drug candidates in clinical development, including CDX-1401, an immunotherapeutic for cancer indications; CDX-301, an immune cell mobilizing agent and dendritic cell growth factor; and CDX-014, an antibody-drug conjugate targeting renal and ovarian cancers. In addition, the company focuses on the discovery and development of antibody-based drugs targeting receptor tyrosine kinases, such as CDX-0158, a humanized monoclonal antibody currently in a Phase 1 dose escalation study in refractory gastrointestinal stromal tumors and other KIT positive tumors; and CDX-3379, a human monoclonal antibody, which has completed a Phase 1b study in patients with solid tumors. Celldex Therapeutics, Inc. has research collaboration and license agreements with Medarex, Inc.; Rockefeller University; University of Southampton; Amgen Inc.; Amgen Fremont; and Seattle Genetics, Inc. The company is headquartered in Hampton, New Jersey.
Read More
How much money does Celldex Therapeutics Inc make?
News & Events about Celldex Therapeutics Inc.
Globe Newswire
1day ago
Company to host webcast on Sunday, February 26 at 4:00 pm CT/5:00 pm ETHAMPTON, N.J., Feb. 03, 2023 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that data from the Companys Phase 1b multi-dose study of barzolvolimab in chronic spontaneous urticaria will be presented ...
Globe Newswire
2 months ago
- Includes oral presentation for 1.5 mg/kg cold urticaria cohort - - Company to host webcast conference call on Tuesday, December 6 at 8:00 am ET - HAMPTON, N.J., Dec. 02, 2022 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that multiple presentations from the ...
Market News Video
4 months ago
In trading on Friday, shares of Celldex Therapeutics, Inc. (CLDX) crossed above their 200 day moving average of 31.81, changing hands as high as 32.45 per share...
Globe Newswire
8 months ago
HAMPTON, N.J., May 19, 2022 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that an abstract describing the Phase 1b study of barzolvolimab (CDX-0159) in patients with antihistamine refractory chronic spontaneous urticaria (CSU), has been accepted as a late-breaking ...
Ticker Report
8 months ago
State Board of Administration of Florida Retirement System boosted its position in shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX Get Rating) by 55.6% in the fourth quarter, HoldingsChannel reports. The fund owned 8,967 shares of the biopharmaceutical companys stock after ...
Frequently Asked Questions
Frequently Asked Questions
What is Celldex Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Celldex Therapeutics Inc shares?
plus_minus_icon
How can I buy Celldex Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Celldex Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Celldex Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Celldex Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Celldex Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Celldex Therapeutics Inc?
plus_minus_icon
What percentage is Celldex Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Celldex Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$46.09
$1.11
(2.47%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00